Prolongation of heart allograft survival of rats treated by a Th2 inhibitor

Transplant Immunology

Volumn 11, Issue 3-4, 2003, Pages 385-388

  Hsu, Li Wen ^a   Goto, Shigeru ^a,b   Lin, Yu Chun ^a   Lai, Chia Yun ^a   Tseng, Hui Peng ^a   Wu, Chia Ling ^a   Lord, Roger ^c   Kitano, Seigo ^d   Chen, Shu Hui ^e   Chen, Chao Long ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b Iwao Hospital   (Japan)

^c UNIVERSITY OF TASMANIA   (Australia)

^d OITA UNIVERSITY   (Japan)

^e NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Cytokines; Heart allograft; IPD; Suplatast tosilate

Indexed keywords

CONCANAVALIN A; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 4; INTERLEUKIN 5; IPD 1151; SODIUM CHLORIDE; SUPLATAST TOSYLATE;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLAST CELL; CELL INFILTRATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; EOSINOPHIL; GRAFT REJECTION; GRAFT SURVIVAL; HEART BEAT; HEART GRAFT; HEART TRANSPLANTATION; IMMUNOGLOBULIN PRODUCTION; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; MALE; MIXED LYMPHOCYTE REACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RAT; TH1 CELL; TH2 CELL;

ANIMALS; ARYLSULFONATES; GRAFT SURVIVAL; HEART TRANSPLANTATION; RATS; SULFONIUM COMPOUNDS; TH2 CELLS; TRANSPLANTATION, HOMOLOGOUS;

EID: 10744226737     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(02)00152-1     Document Type: Article

References (14)

1. Baan CC, Metselaar HJ, Mol WM, et al. Intragraft IL-4 mRNA expression is associated with down-regulation of liver graft rejection. Clin Transplant 1996;10(6 Pt 1):542-549.
2. Ngoc LT, Fumin F, Shiguang Q, et al. Cytokine mRNA profiles in mouse orthotopic liver transplantation. Transplantation 1995;59(2):274-281.
3. Martin S, Zand MS, Yongsheng L, et al. Interleukin-2 and Interferon-γ double knockout mice reject heterotopic cardiac allografts. Transplantation 2000;70(9):1378-1381.
4. Steiger J, Nickerson PW, Steurer W, Moscovitch-Lopatin M, Strom TB. IL-2 knockout recipient mice reject islet cell allografts. J Immunol 1995;155(1):489-498.
5. Saleem S, Konieczny BT, Lowry RP, Baddoura FK. Acute rejection of vascularized heart allografts in the absence of IFN-gamma. Transplantation 1996;62(12):1908-1911.
6. + suppressor T cells that are not dependent upon IL-4. J Immunol 1998;161(10):5147-5156.
7. Yamaya H, Basaki Y, Togawa M, Kojima M, Kiniwa M, Matsuura N. Down-regulation of Th2 cell mediated murine peritoneal eosionophilia by allergic agents. Life Sci 1995;56(19):1647-1654.
8. Yanagihara Y, Kiniwa M, Ikizawa K, Shida T, Matsuura N, Koda A. Suppression of IgE production by IPD-1151T (suplatast tosilate), a new dimethylsufonium agent: (2) Regulation of human IgE response. Jap J Pharmacol 1993;61(4):31-39.
9. Ueda T, Tamaki M, Ogawa O, Yamauchi T, Yoshimura N. Improvement of interstitial cystitis symptoms and problem that developed during treatment with oral IPD-1151T. J Urol 2000;164(6):1917-1920.
10. Green MK, Mandel TE. Experimental transplantation models in small animals. In: Green MK, editor. Rat Heterotopic Heart Transplant Technique. 1995. p. 133-152.
11. Takeuchi T, Lowry RP, Konieczny B. Heart allografts in mouse systems: The differential activation of Th2-like effector cells in peripheral tolerance. Transplantation 1992;53(6):1281-1294.
12. Mosmann TR, Moore KW. The role of IL-10 in crossregulation of TH1 and TH2 responses. Immunol Today 1991;12(3):A49-A53.
13. Fernandez-Botran R, Sanders VM, Mosmann TR, Vitetta ES. Lymphokine-mediated regulation of the proliferative response of clones of T helper 1 and T helper 2 cells. J Exp Med 1998;168(2):543-558.
14. Chen WF, Zlotnik A. IL-10: A novel cytotoxic T cell differentiation factor. J Immunol 1991;147(2):528-534.